These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 6262378

  • 1. Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor.
    Josse RG, Murray TM, Mundy GR, Jez D, Heersche JN.
    J Clin Invest; 1981 May; 67(5):1472-81. PubMed ID: 6262378
    [Abstract] [Full Text] [Related]

  • 2. Bone resorption by isolated chick osteoclasts in culture is stimulated by murine spleen cell supernatant fluids (osteoclast-activating factor) and inhibited by calcitonin and prostaglandin E2.
    de Vernejoul MC, Horowitz M, Demignon J, Neff L, Baron R.
    J Bone Miner Res; 1988 Feb; 3(1):69-80. PubMed ID: 3264994
    [Abstract] [Full Text] [Related]

  • 3. Release of the lymphokine osteoclast activating factor requires cyclic AMP accumulation.
    Yoneda T, Mundy GR.
    Calcif Tissue Int; 1982 Mar; 34(2):204-8. PubMed ID: 6177386
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of osteoclast activating factor from human leukocytes on bone metabolism.
    Raisz LG, Luben RA, Mundy GR, Dietrich JW, Horton JE, Trummel CL.
    J Clin Invest; 1975 Aug; 56(2):408-13. PubMed ID: 1171115
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Big and little forms of osteoclast activating factor.
    Mundy GR, Raisz LG, Shapiro JL, Bandelin JG, Turcotte RJ.
    J Clin Invest; 1977 Jul; 60(1):122-8. PubMed ID: 874077
    [Abstract] [Full Text] [Related]

  • 12. Evidence for multiple bone resorption-stimulating factors produced by normal human keratinocytes in culture.
    Fried RM, Voelkel EF, Rice RH, Levine L, Tashjian AH.
    Endocrinology; 1988 Jun; 122(6):2467-75. PubMed ID: 2453341
    [Abstract] [Full Text] [Related]

  • 13. Delayed stimulation of bone resorption in vitro by phosphodiesterase inhibitors requires the presence of adenylate cyclase stimulation.
    Ransjö M, Fredholm BB, Lerner UH.
    Bone Miner; 1988 Jan; 3(3):225-34. PubMed ID: 2462948
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prostaglandins are necessary for osteoclast-activating factor production by activated peripheral blood leukocytes.
    Yoneda T, Mundy GR.
    J Exp Med; 1979 Jan 01; 149(1):279-83. PubMed ID: 105076
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of glucocorticoids on osteoclast-activating factor.
    Strumpf M, Kowalski MA, Mundy GR.
    J Lab Clin Med; 1978 Nov 01; 92(5):772-8. PubMed ID: 712208
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Potassium effects on bone: comparison of two model systems.
    Krieger NS, Stern PH.
    Am J Physiol; 1983 Sep 01; 245(3):E303-7. PubMed ID: 6604461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.